VIDEO: Better options needed for relapsed mantle cell lymphoma

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

We definitely need more and better options for relapse disease, patients can develop some just intrinsic resistance to treatments and they can burn through therapies relatively quickly when they get into the relapse setting and you could run out of good treatment options. So to have treatments that produced more durable remissions would be desirable, and to have more options would be desirable. Obviously if we could cure mantle cell lymphoma in the frontline setting, (laughs) then we wouldn't need these options for the relapse setting, so that's obviously another unmet need. You know, even though we get good results with our first line treatments, patients generally relapse. We don't really think a mantle cell lymphoma is likely to be cured, and so that's obviously a huge unmet need. If we could come up with curative approaches for mantle cell lymphoma, that would be a huge advance for the field.